Carbon Biosciences Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 16

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $38M

  • Investors
  • 11

Carbon Biosciences General Information

Description

Developer of a gene therapy platform intended for the treatment of rare and genetic diseases. The company utilizes a proprietary library of novel parvovirus-based vectors designed to deliver larger genetic payloads with high tissue specificity and minimal immune response, enabling the biotechnology and healthcare markets to advance genetic medicines through improved viral delivery systems that support repeatable dosing and targeted pulmonary and cardiac applications.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 880 Winter Street
  • Suite 2001
  • Waltham, MA 02451
  • United States
+1 (617)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 880 Winter Street
  • Suite 2001
  • Waltham, MA 02451
  • United States
+1 (617)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Carbon Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 21-Jun-2022 $38M Completed Generating Revenue
1. Accelerator/Incubator Completed Stealth
To view Carbon Biosciences’s complete valuation and funding history, request access »

Carbon Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Carbon Biosciences’s complete cap table history, request access »

Carbon Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a gene therapy platform intended for the treatment of rare and genetic diseases. The company utilizes a pro
Drug Discovery
Waltham, MA
16 As of 2026

Emeryville, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Carbon Biosciences Competitors (1)

One of Carbon Biosciences’s competitors is 4D Molecular Therapeutics, a Formerly VC-backed company based in Emeryville, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
4D Molecular Therapeutics Formerly VC-backed Emeryville, CA
You’re viewing 1 of 1 competitors. Get the full list »

Carbon Biosciences Patents

Carbon Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026072721-A1 Parvovirus compositions and methods for gene therapy Pending 25-Sep-2024
WO-2026064736-A1 Parvovirus compositions and related methods for gene therapy Pending 23-Sep-2024
WO-2026064739-A1 Parvovirus compositions and related methods for gene therapy Pending 23-Sep-2024
EP-4683931-A1 Parvovirus compositions and related methods for gene therapy Pending 23-Mar-2023
US-20260265310-A1 Parvovirus compositions and related methods for gene therapy Pending 23-Mar-2023 C07K14/015
To view Carbon Biosciences’s complete patent history, request access »

Carbon Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Carbon Biosciences Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Agent Capital Venture Capital Minority
AJU IB Investment Venture Capital Minority
Astellas Venture Management Corporate Venture Capital Minority
Camford Capital Venture Capital Minority
Cystic Fibrosis Foundation Limited Partner Minority
You’re viewing 5 of 11 investors. Get the full list »

Carbon Biosciences FAQs

  • When was Carbon Biosciences founded?

    Carbon Biosciences was founded in 2021.

  • Where is Carbon Biosciences headquartered?

    Carbon Biosciences is headquartered in Waltham, MA.

  • What is the size of Carbon Biosciences?

    Carbon Biosciences has 16 total employees.

  • What industry is Carbon Biosciences in?

    Carbon Biosciences’s primary industry is Drug Discovery.

  • Is Carbon Biosciences a private or public company?

    Carbon Biosciences is a Private company.

  • What is the current valuation of Carbon Biosciences?

    The current valuation of Carbon Biosciences is .

  • What is Carbon Biosciences’s current revenue?

    The current revenue for Carbon Biosciences is .

  • How much funding has Carbon Biosciences raised over time?

    Carbon Biosciences has raised $38M.

  • Who are Carbon Biosciences’s investors?

    Agent Capital, AJU IB Investment, Astellas Venture Management, Camford Capital, and Cystic Fibrosis Foundation are 5 of 11 investors who have invested in Carbon Biosciences.

  • Who are Carbon Biosciences’s competitors?

    4D Molecular Therapeutics is a competitor of Carbon Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process